In the prespecified subgroup of 798 individuals with data on APOE4, higher cumulative mean poststroke glucose level was associated with a faster global cognitive decline before and after adjusting for poststroke SBP and LDL cholesterol levels. The gene discussed is APOE; the disease is Mental deterioration.